Severe acute renal failure in patients treated with glucagon-like peptide-1 receptor agonists

Diabetes Research and Clinical Practice

Volumn 103, Issue 3, 2014, Pages

  Dubois Laforgue, D ^a,c   Boutboul, D ^a,c   Levy D J ^a,c   Joly, D ^b,c   Timsit, J ^a,c  

^a Institut Cochin   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Acute interstitial nephritis; Acute renal failure; Exenatide; Glucagon like peptide 1 receptor agonists; Liraglutide; Type 2 diabetes mellitus

Indexed keywords

ACUTE INTERSTITIAL NEPHRITIS; ACUTE RENAL FAILURE; EXENATIDE; GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS; LIRAGLUTIDE; TYPE 2 DIABETES MELLITUS;

ACUTE KIDNEY INJURY; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCAGON-LIKE PEPTIDE 1; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, GLUCAGON; RENAL DIALYSIS;

EID: 84898904491     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2013.11.014     Document Type: Article

References (9)

1. Bhatti R. Exenatide associated renal failure. Pract Diabetes Int 2010, 27:232-234.
2. Johansen O.E., Whitfield R. Exenatide may aggravate moderate diabetic renal impairment: a case report. Br J Clin Pharmacol 2008, 66:568-569.
3. Weise W.J., Sivanandy M.S., Block C.A., Comi R.J. Exenatide-associated ischemic renal failure. Diabetes Care 2009, 32:e22-e23.
4. Lopez-Ruiz A., del Peso-Gilsanz C., Meoro-Aviles A., Soriano-Palao J., Andreu A., Cabezuelo J., et al. Acute renal failure when exenatide is co-administred with diuretics and angiotensin II blockers. Pharm World Sci 2010, 32:559-561.
5. Ferrer-Garcia J.C., Martinez-Chanza N., Tolosa-Torréns M., Sanchez-Juan C. Exenatide and renal failure. Diabet Med 2010, 27:728-729.
6. Nandakoban H., Furlong T.J., Flack J.R. Acute tubulointerstitial nephritis following treatment with exenatide. Diabet Med 2013, 30:123-125.
7. Linnebjerg H., Kothare P.A., Park S., Mace K., Reddy S., Mitchell M., et al. Effect of renal impairment on the pharmacokinetics of exenatide. Br J Clin Pharmacol 2007, 64:317-327.
8. Kaakeh Y., Kanjee S., Boone K., Sutton J. Liraglutide-induced acute kidney injury. Pharmacotherapy 2012, 32:e7-e11.
9. Kim M., Platt M.J., Shibasaki T., Quaggin S.E., Backx P.H., Seino S., et al. GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure. Nat Med 2013, 19:567-575.